سعر فوتاتريت 100 مجم / مل 100 مل محلول بالفم 2025

Levetiracetam 100 mg/ml oral solution, 100 ml bottle, by Future Pharmaceutical Industries (Egypt); antiepileptic.

• Partial-onset seizures in patients 1 month of age and older (US label).Population: Patients 1 month and olderDailyMed (U.S. National Library of Medicine)
• Adjunctive therapy of myoclonic seizures in juvenile myoclonic epilepsy (12 years and older) and of primary generalized tonic-clonic seizures (6 years and older) (US label).Population: Patients 6 years and olderDailyMed (U.S. National Library of Medicine)

• Most common adverse reactions in adults (partial-onset seizures): somnolence, asthenia, infection and dizziness.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Known hypersensitivity to levetiracetam (anaphylaxis and angioedema have occurred).International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Behavioural abnormalities and psychotic symptoms, suicidal behaviour and ideation, somnolence and fatigue, coordination difficulties, hematologic abnormalities, and serious skin reactions (SJS/TEN) and DRESS.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Withdraw gradually to reduce the risk of increased seizure frequency and status epilepticus; plasma levels may fall during pregnancy, especially in the third trimester.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Prolonged experience in pregnant women has not identified a drug-associated risk of major birth defects or miscarriage; a pregnancy exposure registry exists.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Levetiracetam is excreted in human milk; no data on effects on the breastfed infant; weigh benefits of breastfeeding against maternal need.International label, same formulation · DailyMed (U.S. National Library of Medicine)

English text not available for this section.